🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, pharmacokinetics and p...
Status
Completed
Location
Seoul National University Hospital,Clinical Trial Center/ Clinical Research Institute
Start Date
2011-09
Trial ID
NCT01440686
Treatments Being Tested
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
The goal of this interventional study is to evaluate the pharmacokinetics, ...
Status
Unknown
Location
ICBio Clinical Research Pvt. Ltd.
Start Date
2022-10-29
Trial ID
NCT05619770
Treatments Being Tested
This study is aimed to evaluate the progression-free survival(PFS) and also...
Status
Unknown
Location
The First Affiliated Hospital of AnHui Medical University
Start Date
2015-02
Trial ID
NCT02348450
Treatments Being Tested
The main purpose of this study is to validate the ultrasound scores PsASon2...
Status
Withdrawn
Location
Medical University of Graz
Start Date
2020-07-01
Trial ID
NCT04102449
Treatments Being Tested
In this study, patients with relapsed or refractory ovarian cancer will rec...
Status
Terminated
Location
Florida Cancer Specialists
Start Date
2010-01
Trial ID
NCT01035658
This is a phase I/II, open-label, dose escalation and dose extension study ...
Status
Terminated
Location
Shanghai East Hospital
Start Date
2021-05-20
Trial ID
NCT04882176
Treatments Being Tested
This is a Phase I, single-center trial to assess the safety, tolerability, ...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2026-02-05
Trial ID
NCT07409922
Treatments Being Tested
The study will evaluate the hypothesis that at doses and plasma concentrati...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01098877
This is a randomised, double-blind, placebo-controlled and ascending single...
Status
Completed
Location
Hammersmith Medicines Research Ltd.
Start Date
2014-03
Trial ID
NCT02107885